These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 4015265)
1. Therapeutic range for the control of oral anticoagulant therapy. Hirsch J Arch Intern Med; 1985 Jul; 145(7):1187-8. PubMed ID: 4015265 [No Abstract] [Full Text] [Related]
2. Confusion over the therapeutic range for monitoring oral anticoagulant therapy in North America. Hirsh J; Levine M Thromb Haemost; 1988 Apr; 59(2):129-32. PubMed ID: 3291180 [No Abstract] [Full Text] [Related]
3. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms. Crowther MA Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458 [TBL] [Abstract][Full Text] [Related]
5. [Control of oral anticoagulant therapy. The Quick method is one step back]. Larson G; Stigendal L; Dahlbäck B; Berntorp E; Egberg N; Johnsson H Lakartidningen; 1993 Aug; 90(34):2781. PubMed ID: 8366716 [No Abstract] [Full Text] [Related]
6. [External quality control and standardization of prothrombin time determination for the monitoring of oral anticoagulant treatment in the Netherlands]. van Duuk-Wierda CA; Loeliger EA; Roos J Ned Tijdschr Geneeskd; 1980 Jan; 124(4):103-7. PubMed ID: 7374832 [No Abstract] [Full Text] [Related]
7. Measurement of prothrombin time in patients on oral anticoagulant therapy: effect of two different evacuated tubes. D'Angelo G; Villa C Haematologica; 1999 Jul; 84(7):656-7. PubMed ID: 10406912 [No Abstract] [Full Text] [Related]
8. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK). Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929 [TBL] [Abstract][Full Text] [Related]
9. [Current biological surveillance of oral anticoagulant treatment]. Helft G; Vacheron A; Samama MM Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Anderson DR; Harrison L; Hirsh J Arch Intern Med; 1993 Jun; 153(12):1441-7. PubMed ID: 8512435 [TBL] [Abstract][Full Text] [Related]
12. Home prothrombin time monitoring: a literature analysis. Yang DT; Robetorye RS; Rodgers GM Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909 [TBL] [Abstract][Full Text] [Related]
13. [Self management of peroral anticoagulant therapy in patients with artificial heart valves]. Hasenkam JM; Kimose HH; Grønnesby H; Andersen NT; Halborg J; Attermann J; Knudsen L; Christensen TD; Pedersen AM; Lyngbak M; Pilegaard HK Ugeskr Laeger; 1998 Nov; 160(47):6811-5. PubMed ID: 9835790 [TBL] [Abstract][Full Text] [Related]
14. A clinical study monitoring low-intensity anticoagulant therapy with a standard-sensitivity thromboplastin. Brophy MT; Fiore LD; Lau J; Headley E; Allen M; Deykin D Arch Pathol Lab Med; 1993 Jun; 117(6):618-21. PubMed ID: 8503734 [TBL] [Abstract][Full Text] [Related]